siRNA treatment lowers triglycerides in clients along with unusual condition

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran reduced triglyceride amounts by 80% and also decreased the threat of pancreatitis in patients along with consistent chylomicronemia, with or even without a hereditary diagnosis.